Team

Amid a record-breaking elective backlog in England, NHS England has opted to flex its newly-granted financial powers by proposing a partial return to the Payment by Results system for acute care. But does this seemingly technical rewiring of the NHS’s financial flow have actual political and business salience? The answer is yes, and here is why. 

The COVID-19 pandemic has shone a light on the fragility of the public health systems that we take for granted. As the virulence of the pandemic begins to abate across much of the world, how exposed – or prepared – are counties for the impact of war, economic sanctions, political isolation and new migratory patterns on existing health structures and systems? 

Mark Loughridge, Dr Rupert Lewis, Andrew Croydon and Miranda Lutz discuss the ‘science gap’ between government and scientists.

In September, the UK Medicines and Healthcare products Regulatory Agency (MHRA) issued its long-anticipated consultation on the UK’s post Brexit medical devices regime. For all the early talk of substantial divergence from existing EU rules, the UK Government is in fact proposing greater regulatory alignment and a focus on pathways so far not offered by other major…